Literature DB >> 29318002

The hope, hype and reality of Big Data for pharmacovigilance.

Andrew Bate1, Robert F Reynolds2, Patrick Caubel3.   

Abstract

Entities:  

Year:  2017        PMID： 29318002      PMCID： PMC5753994          DOI： 10.1177/2042098617736422

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  32 in total

1.  THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.

Authors:  D J FINNEY
Journal:  J Chronic Dis       Date:  1965-01

2.  The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.

Authors:  R Ball; M Robb; S A Anderson; G Dal Pan
Journal:  Clin Pharmacol Ther       Date:  2016-01-12       Impact factor: 6.875

Review 3.  Quantitative signal detection using spontaneous ADR reporting.

Authors:  A Bate; S J W Evans
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-06       Impact factor: 2.890

4.  Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Authors:  Anil Mor; Trine Frøslev; Reimar Wernich Thomsen; Alessandro Oteri; Peter Rijnbeek; Tania Schink; Edeltraut Garbe; Serena Pecchioli; Francesco Innocenti; Irene Bezemer; Elisabetta Poluzzi; Miriam C Sturkenboom; Gianluca Trifirò; Mette Søgaard
Journal:  Infection       Date:  2015-04-01       Impact factor: 3.553

5.  Systemic signalling of adverse reactions to drugs.

Authors:  D J Finney
Journal:  Methods Inf Med       Date:  1974-01       Impact factor: 2.176

6.  Assessment of adverse reactions within a drug surveillance program.

Authors:  I T Borda; D Slone; H Jick
Journal:  JAMA       Date:  1968-08-26       Impact factor: 56.272

7.  Medicaid drug-event data: an emerging tool for evaluation of drug risk.

Authors:  J K Jones; S W Van de Carr; F Rosa; L Morse; A LeRoy
Journal:  Acta Med Scand Suppl       Date:  1984

8.  Asthma in life context: Video Intervention/Prevention Assessment (VIA)

Authors:  M Rich; S Lamola; C Amory; L Schneider
Journal:  Pediatrics       Date:  2000-03       Impact factor: 7.124

9.  Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?

Authors:  Vera E Valkhoff; René Schade; Geert W 't Jong; Silvana Romio; Martijn J Schuemie; Andrea Arfe; Edeltraut Garbe; Ron Herings; Silvia Lucchi; Gino Picelli; Tania Schink; Huub Straatman; Marco Villa; Ernst J Kuipers; Miriam C J M Sturkenboom
Journal:  BMC Pediatr       Date:  2013-11-19       Impact factor: 2.125

10.  Launching PCORnet, a national patient-centered clinical research network.

Authors:  Rachael L Fleurence; Lesley H Curtis; Robert M Califf; Richard Platt; Joe V Selby; Jeffrey S Brown
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497
View more
  12 in total

1.  Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".

Authors:  Cedric Bousquet; Bissan Audeh; Florelle Bellet; Agnès Lillo-Le Louët
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

2.  From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data.

Authors:  Vassilis Koutkias
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

3.  Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.

Authors:  Stella Stergiopoulos; Mortiz Fehrle; Patrick Caubel; Louise Tan; Louise Jebson
Journal:  Pharmaceut Med       Date:  2019-12

Review 4.  Data Science for Child Health.

Authors:  Tellen D Bennett; Tiffany J Callahan; James A Feinstein; Debashis Ghosh; Saquib A Lakhani; Michael C Spaeder; Stanley J Szefler; Michael G Kahn
Journal:  J Pediatr       Date:  2019-01-25       Impact factor: 4.406

Review 5.  Medicines in pregnancy.

Authors:  Sarah Je Stock; Jane E Norman
Journal:  F1000Res       Date:  2019-06-20

6.  Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

Authors:  Andrew Bate; Ken Hornbuckle; Juhaeri Juhaeri; Stephen P Motsko; Robert F Reynolds
Journal:  Ther Adv Drug Saf       Date:  2019-08-05

7.  Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.

Authors:  George I Gavriilidis; Vlasios K Dimitriadis; Marie-Christine Jaulent; Pantelis Natsiavas
Journal:  Drug Saf       Date:  2021-10-21       Impact factor: 5.606

8.  Factors that influence the intention to use mobile phone caller tunes for patient reporting of adverse drug reactions: a qualitative study.

Authors:  Bernard Appiah; Anubhuti Poudyal; James N Burdine; Lucy Asamoah-Akuoko; David Anidaso Anum; Irene Akwo Kretchy; George Sabblah; Alexander N O Dodoo; E Lisako J McKyer
Journal:  Ther Adv Drug Saf       Date:  2019-09-14

9.  Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study.

Authors:  Craig S Jabaley; Francis A Wolf; Grant C Lynde; Vikas N O'Reilly-Shah
Journal:  Ther Adv Drug Saf       Date:  2018-04-18

10.  Artificial Intelligence, Real-World Automation and the Safety of Medicines.

Authors:  Andrew Bate; Steve F Hobbiger
Journal:  Drug Saf       Date:  2020-10-07       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.